A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

NCT01468688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

3rd Line GIST

Interventions

DRUG: STI571
DRUG: BKM120

Sponsor

Novartis Pharmaceuticals